Pular para o conteúdo principal
Ranking Invest

CRL - Charles River Laboratories International, Inc.

Segmento: HealthcareCharles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Análise Ranking Invest

Valor de Mercado
$ 18.01 Bi
IVR
0.19Índice proprietário de comparação relativa: 0,19.
IVR2
0.03Leitura proprietária complementar: 3%.
MLL
0.03Leitura proprietária complementar: 3%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 2.83 Bi

Dívida Líquida

-$ 186.56 Mi

L4T

-$ 238.46 Mi

MM4T

-6.01%

Indicadores Básicos

ROE

-8.42%

Índices de Previsibilidade

Receita Líquida

A0.02

Lucro

F3.96

Margem

F3.08

Índices de Tendência

Receita Líquida

E-6.24

Lucro

F-7.15

Margem

F-7.05

Índices de Endividamento

DIV/PAT

-0.07

DIV/L4T

0.78

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.